464 related articles for article (PubMed ID: 7059979)
1. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice.
Friedman HS; Schold SC; Varia M; Bigner DD
Cancer Res; 1983 Jul; 43(7):3088-93. PubMed ID: 6850617
[TBL] [Abstract][Full Text] [Related]
4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
5. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
6. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; VĂ©nuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
7. Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kligerman AD; Erexson GL; Wilmer JL; Schold SC
Cancer Res; 1987 Jan; 47(2):631-5. PubMed ID: 3791247
[TBL] [Abstract][Full Text] [Related]
8. New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
Abernathey CD; Kooistra KL; Wilcox GL; Laws ER
Neurosurgery; 1988 May; 22(5):877-81. PubMed ID: 2837674
[TBL] [Abstract][Full Text] [Related]
9. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.
Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
Clin Cancer Res; 1999 Nov; 5(11):3676-81. PubMed ID: 10589786
[TBL] [Abstract][Full Text] [Related]
10. Human brain tumor xenografts in nude mice as a chemotherapy model.
Houchens DP; Ovejera AA; Riblet SM; Slagel DE
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):799-805. PubMed ID: 6683650
[TBL] [Abstract][Full Text] [Related]
11. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
12. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
Gutin PH; Bernstein M; Sano Y; Deen DF
Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
15. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
16. Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.
Schold SC; Bigner DD
Cancer Treat Rep; 1983 Sep; 67(9):811-9. PubMed ID: 6224556
[TBL] [Abstract][Full Text] [Related]
17. [Effect of perfluorochemicals on BCNU chemotherapy in a rat brain-tumor model].
Kokunai T; Kuwamura K
No To Shinkei; 1982 Jun; 34(6):609-15. PubMed ID: 7115598
[TBL] [Abstract][Full Text] [Related]
18. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]